02/04/2026
Most healthcare roundtables hear from operators and investors. We did something different. We put general counsel in the room and asked what they really think: where are the opportunities, the risks, and what keeps them up at night?
What followed was a candid discussion on the state of independent healthcare in the UK.
The headline is clear: the sector is moving fast and that pace is creating legal and governance challenges. GCs are being asked to anticipate risk, strengthen organisational resilience, support decision-making, and add value in an environment that refuses to stand still.
The backdrop
Consolidation continues. The self-pay market is growing, largely driven by younger consumers who treat healthcare as something they choose to buy rather than a system to belong to. At the same time, neighbourhood-based care models, preventative medicine, and wellness services are opening up genuine commercial opportunities.
Overlaying this is a shifting political and economic landscape. The consolidation of Integrated Care Boards and the emergence of larger regional commissioning bodies raise important questions for independent providers.
These dynamics bring both opportunity and pressure. The GC function is expected to be at the centre of these opportunities, without sacrificing technical expertise and compliance.
The interaction between the NHS and Independent providers
The condition of the NHS and the impact of ongoing structural reform remain a central concern. National reconfiguration is introducing commercial, legal, and operational risk, particularly where contracts may be terminated early. This uncertainty affects forecasts and workforce planning.
The much-discussed 10-year plan is promising, but its structure means that output isn’t currently visible. More beds and investment are required but the system can be inwardly focussed, concerned with hitting its own budgets and targets.
A consistent view emerged: social care and the NHS cannot be solved in isolation. The Casey report highlights a power imbalance, where NHS interests override those of social care.
AI is here to stay – nuance is key
The impact and benefits of AI in clinical use settings have been well documented, what’s more opaque is it’s use operationally, by internal teams.
One point was unequivocal: legal teams are already using AI. The productivity gains are real, but so are the risks. Hallucinations in document review are not theoretical; they are happening. The consensus was clear: AI cannot be left unchecked, it requires structure, oversight, and control.
The regulatory framework governing AI remains fragmented. Cybersecurity, data governance, and AI risks were flagged as areas where board attention is required. The absence of regulatory guidance makes it the GC’s responsibility to manage in the meantime.
The opportunity in harnessing technological innovation and AI is significant. AI that enhances clinical decision making, streamlines administrative tasks, and enhances patient outcomes needs to be embraced. However, there is no substitute for a senior lawyer’s judgement, especially when the stakes are high. AI handles volume well, but it doesn’t handle nuance. It accelerates the process, but it doesn’t replace the professional.
Workforce Shifts
No healthcare discussion is complete without workforce.
The Employment Rights Act and the myriad of changes expected over the next 2 years creates operational complexity, particularly around temporary and agency staff. Twelve weeks of regular work will trigger an obligation to offer guaranteed minimum hours. Managing outsourced and contracted workforces is becoming more challenging, and probation processes will need to be reviewed and strengthened to mitigate unfair dismissal risks, with the qualifying period of service reducing to 6 months. As strategic organisational issues, with far reaching operational implications, the cost of the reforms should be priced into both cost and risk models.
At the same time, the consultant model is evolving. How younger consultants want to work is changing, alongside patient demographics and expectations. How GCs and senior legal leaders structure contracts is starting to reflect these shifts.
Conclusions – GCs are strategic partners
Healthcare law is consequential and the decisions legal teams support affect patients, staff, investors, and communities. Today’s GCs are not back-office advisors. They are strategic partners helping organisations navigate one of the most complex operating environments in the sector’s history.
A consistent theme throughout was that healthcare remains fundamentally about people and quality. Organisations that successfully balance regulatory compliance, workforce capability, technological adoption and capital deployment will be best positioned to navigate uncertainty and capitalise on what is seen as an exciting and transformative period for the sector.
Independent healthcare has the capital, the capability and increasingly the public permission to play a much bigger role in how this country delivers care. Whether it can move fast enough and govern carefully enough to capitalise on that moment is, in so small part, a legal question.
This article reflects themes from a private General Counsel Exchange roundtable. Views are drawn from collective discussion and do not represent the position of any individual attendee or organisation.
For expert legal perspectives on the sector, follow our dedicated Independent Health, Care & Life Sciences page.
